Review Article

Alzheimer’s Disease and HLA-A2: Linking Neurodegenerative to Immune Processes through an In Silico Approach

Table 1

Description of the included articles.

StudyCountry/population
Cases/controlsTyping/techniqueDiagnostic criteriaReference

Henschke et al., 1978Canada34/239LymphotoxicityExclusion of other causes of dementia [21]
Sulkava et al., 1980
Finland32/35LymphotoxicityExclusion of other causes of dementia[22]
Wilcox et al., 1980
United Kingdom18/342LymphotoxicityExclusion of other causes of dementia[23]
Whalley et al., 1980
United Kingdom14/64LymphotoxicityExclusion of other causes of dementia[24]
Majsky and Vojtechovsky, 1983Czechoslovakia38/301LymphotoxicityExclusion of other causes of dementia-Haschinsky [25]
Reed et al., 1983
United States44/100LymphotoxicityExclusion of other causes of dementia[26]
Reisner et al., 1983United States52/305Amos modified methodHistopathological confirmation [27]
Renvoize, 1984
United Kingdom124/458Lympho-toxicityExclusion of other causes of dementia[28]
Endo et al., 1986
Japan122/66Lympho-toxicityDSM III[36]
Small and Matsuyama, 1986
United States36/25Lympho-toxicityDSM III[29]
Payami et al., 1991
United States 54/263LymphotoxicityNINCDS-ADRDA[30]
Middleton et al., 1999
United Kingdom95/45PCR SSOPHistopathological confirmation[31]
Small et al., 1999
United States479/233PCR SSPNINCDS-ADRDA[32]
Harris et al., 2000
United Kingdom178/161PCR SSPNINCDS-ADRDA[12]
Lehmann et al., 2001
United Kingdom 55/73PCR SSPHistopathological confirmation CERAD[11]
Araria-Goumidi et al., 2002
France451/477Duplex-PCRDSM III and NINCDS-ADRDA[33]
Listì et al., 2006Italy 460/266PCR SSP NINCDS-ADRDA[34]
Ma et al., 2008
China160/167SBTNINCDS-ADRDA[13]
Guerini et al., 2009Italy173/258PCR SSPNINCDS-ADRDA[35]

AD: Alzheimer’s disease, PCR SSOP: Polymerase chain reaction and sequence specific oligonucleotide probe, PCR SSP: Polymerase chain reaction and sequence specific primers, SBT: Sequence based typing, DSM: Diagnostic and Statistical Manual, NINCDS-ADRDA: National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association, CERAD: Consortium to Establish a Registry for Alzheimer’s Disease.